Key New Findings Across Brain and Behavior Today's new findings show that: Combining low doses of the drug tirzepatide, a "dual agonist" that works, in part, by activating GLP-1 receptors, with the hormone oxytocin results in weight loss without gastrointestinal side effects in obese rats
Weve looked at what we know about GLP-1 medications, like Wegovy and semaglutide
Diet pills, caffeine, laxatives, and others have been around for a long time, but with the emergence of GLP-1s, more reports of disordered eating have surfaced
Its more comprehensive for those looking for energy and weight support
Our programs are designed to be as affordable as they are effective
GNL working synthesis